These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12074311)

  • 41. Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease).
    Palmer DN; Jolly RD; van Mil HC; Tyynelä J; Westlake VJ
    Neuropediatrics; 1997 Feb; 28(1):45-8. PubMed ID: 9151321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysine methylation of mitochondrial ATP synthase subunit c stored in tissues of dogs with hereditary ceroid lipofuscinosis.
    Katz ML; Christianson JS; Norbury NE; Gao CL; Siakotos AN; Koppang N
    J Biol Chem; 1994 Apr; 269(13):9906-11. PubMed ID: 8144584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal ceroid lipofuscinosis in a Vietnamese pot-bellied pig (Sus scrofa).
    Cesta MF; Mozzachio K; Little PB; Olby NJ; Sills RC; Brown TT
    Vet Pathol; 2006 Jul; 43(4):556-60. PubMed ID: 16847000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manifestation of neuronal ceroid lipofuscinosis in Australian Merino sheep: observations on altered behaviour and growth.
    Cronin GM; Beganovic DF; Sutton AL; Palmer D; Thomson PC; Tammen I
    Appl Anim Behav Sci; 2016 Feb; 175():32-40. PubMed ID: 26949278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
    Tokola AM; Salli EK; Åberg LE; Autti TH
    Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceroid-lipofuscinosis (Batten's disease): pathogenesis and sequential neuropathological changes in the ovine model.
    Jolly RD; Shimada A; Dopfmer I; Slack PM; Birtles MJ; Palmer DN
    Neuropathol Appl Neurobiol; 1989; 15(4):371-83. PubMed ID: 2779737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study.
    Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
    Acta Neuropathol; 1995; 89(5):391-8. PubMed ID: 7618436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sphingolipid activator proteins (SAPs) in neuronal ceroid lipofuscinoses (NCL).
    Tyynelä J; Suopanki J; Baumann M; Haltia M
    Neuropediatrics; 1997 Feb; 28(1):49-52. PubMed ID: 9151322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autofluorescence emission spectra of neuronal lipopigment in animal and human ceroidoses (ceroid-lipofuscinoses).
    Dowson JH; Armstrong D; Koppang N; Lake BD; Jolly RD
    Acta Neuropathol; 1982; 58(2):152-6. PubMed ID: 6891164
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuronal ceroid-lipofuscinosis in a Labrador Retriever.
    Rossmeisl JH; Duncan R; Fox J; Herring ES; Inzana KD
    J Vet Diagn Invest; 2003 Sep; 15(5):457-60. PubMed ID: 14535546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.
    Siintola E; Partanen S; Strömme P; Haapanen A; Haltia M; Maehlen J; Lehesjoki AE; Tyynelä J
    Brain; 2006 Jun; 129(Pt 6):1438-45. PubMed ID: 16670177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnoses of neuronal ceroid-lipofuscinosis by immunochemical methods.
    Hosain S; Kaufmann WE; Negrin G; Watkins PA; Siakotos AN; Palmer DN; Naidu S
    Am J Med Genet; 1995 Jun; 57(2):239-45. PubMed ID: 7668338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth factor-induced neurite growth in primary neuronal cultures of dogs with neuronal ceroid lipofuscinosis.
    Dunn WA; Raizada MK; Vogt ES; Brown EA
    Int J Dev Neurosci; 1994 Jun; 12(3):185-96. PubMed ID: 7942092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceroid lipofuscinosis in the border collie dog: retinal lesions in an animal model of juvenile Batten disease.
    Taylor RM; Farrow BR
    Am J Med Genet; 1992 Feb; 42(4):622-7. PubMed ID: 1319117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel MFSD8 mutation in a Russian patient with neuronal ceroid lipofuscinosis type 7: a case report.
    Kozina AA; Okuneva EG; Baryshnikova NV; Krasnenko AY; Tsukanov KY; Klimchuk OI; Kondakova OB; Larionova AN; Batysheva TT; Surkova EI; Shatalov PA; Ilinsky VV
    BMC Med Genet; 2018 Aug; 19(1):151. PubMed ID: 30144815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phospholipid fatty acids in brains of normal sheep and sheep with ceroid-lipofuscinosis.
    Palmer DN; Husbands DR; Jolly RD
    Biochim Biophys Acta; 1985 Apr; 834(2):159-63. PubMed ID: 4039608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The neuronal ceroid-lipofuscinoses: from past to present.
    Haltia M
    Biochim Biophys Acta; 2006 Oct; 1762(10):850-6. PubMed ID: 16908122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease.
    Damme M; Brandenstein L; Fehr S; Jankowiak W; Bartsch U; Schweizer M; Hermans-Borgmeyer I; Storch S
    Neurobiol Dis; 2014 May; 65():12-24. PubMed ID: 24423645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.